Skip to main content
Premium Trial:

Request an Annual Quote

OmicaBio, GenobankIo Partner on Tokenized Consent Protocol for Sequencing Study

NEW YORK — OmicaBio, a population genomics startup focused on diversity genomic research in Latin America, said on Tuesday that it has partnered with anonymous DNA test kit provider GenobankIo on the development of a tokenized consent protocol.

According to OmicaBio, it will use GenobankIo's web3 data-management technology to roll out the protocol as part of an effort to sequence 10,000 whole genomes from rare disease patients throughout Mexico and Central America.

Mexico City-based OmicaBio said it has also made an undisclosed investment in GenobankIo as part of the arrangement. Additional terms were not disclosed.

"The aim of this collaboration is to offer research participants unprecedented transparency and traceability over the use of their genomic and clinical data," GenobankIo Founder and CEO Daniel Uribe said in a statement.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.